These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 15447698)
1. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R; Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698 [TBL] [Abstract][Full Text] [Related]
3. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study. Bell CF; Foley KA; Barlas S; Solomon G; Hu XH Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170 [TBL] [Abstract][Full Text] [Related]
4. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
5. Early treatment of migraine with rizatriptan: a placebo-controlled study. Mathew NT; Kailasam J; Meadors L Headache; 2004; 44(7):669-73. PubMed ID: 15209688 [TBL] [Abstract][Full Text] [Related]
6. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference. Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A; Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944 [TBL] [Abstract][Full Text] [Related]
7. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group. Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207 [TBL] [Abstract][Full Text] [Related]
8. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study. Freitag F; Taylor FR; Hamid MA; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders. Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681 [TBL] [Abstract][Full Text] [Related]
10. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606 [TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of short-term preventive frovatriptan: a combined analysis. MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. Martin V; Cady R; Mauskop A; Seidman LS; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144 [TBL] [Abstract][Full Text] [Related]
13. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study]. Mateos V; Roig C; López Rodríguez I; López-Gil A Neurologia; 2002 Dec; 17(10):621-7. PubMed ID: 12487957 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Rizatriptan 10 mg administered early in a migraine attack. Cady R; Martin V; Mauskop A; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F Headache; 2006 Jun; 46(6):914-24. PubMed ID: 16732837 [TBL] [Abstract][Full Text] [Related]
16. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. Krymchantowski AV; Filho PF; Bigal ME Cephalalgia; 2006 Jul; 26(7):871-4. PubMed ID: 16776704 [TBL] [Abstract][Full Text] [Related]